September 10, 2025Frontiers in ImmunologyOpen Access

Case Report: Three cases with allogeneic CIK therapy against solid tumors

View Full Paper

Ask AI

Bookmark

CIK cell therapy significantly improved outcomes in patients with solid tumors, even without preceding chemotherapy.
The three cases included patients with renal cancer, advanced gastric cancer, and hepatocellular carcinoma, all benefiting from treatment.
Adoption of CIK therapy was recommended for patients unable to tolerate traditional chemotherapy due to specific health conditions.
These findings may suggest CIK cell therapy as a viable alternative especially where standard treatments fall short.

Discussion

No takes yet. Share an insight, caveat, or question.

Case report highlights benefits of CIK therapy for solid tumors in chemotherapy-intolerant patients, suggesting new options.

Li et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark